Insiders are Buying and Selling These Healthcare Stocks in 2011

Wall St. Watchdog uncovers companies in the Healthcare sector whose insiders have bought and sold shares over the previous six months.  The companies’ market capitalizations range from $500 million to $1 billion.

  • ImmunoGen, Inc. (NASDAQ:IMGN): Over the past six months, insiders have bought 16,670 shares and have sold -156,670 shares, for a net of -140,000 shares. The shares recently traded at $12.91 and its market capitalization is $969,808,300. About the company: ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company’s tumor activated prodructs deliver chemotherapy specifically to a tumor. ImmunoGen has three drugs in clinical trials and is negotiating to take a drug into phase II trial. These products are being tested for the treatment of colorectal and small-cell lung cancer.
  • NxStage Medical, Inc. (NASDAQ:NXTM): Over the past six months, insiders have bought 474,260 shares and have sold -1,049,410 shares, for a net of -575,150 shares. The shares recently traded at $17.74 and its market capitalization is $963,140,600. About the company: NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company’s primary product, the NxStage System One, is a small, portable hemodialysis system.
  • Neogen Corporation (NASDAQ:NEOG): Over the past six months, insiders have bought 65,070 shares and have sold -120,000 shares, for a net of -54,930 shares. The shares recently traded at $40.07 and its market capitalization is $933,711,100. About the company: Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company’s diagnostic products are used by food and animal producers to test for foodborne bacteria, food allergen, natural toxins, drug and chemical residues, plant diseases, and quality assurance.
  • Insulet Corporation (NASDAQ:PODD): Over the past six months, insiders have bought 505,260 shares and have sold -364,080 shares, for a net of 141,180 shares. The shares recently traded at $19.29 and its market capitalization is $907,154,700. About the company: Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
  • ArthroCare Corporation (NASDAQ:ARTC): Over the past six months, insiders have bought 206,840 shares and have sold -151,080 shares, for a net of 55,760 shares. The shares recently traded at $33.00 and its market capitalization is $901,280,000. About the company: ArthroCare Corporation is multi-business medical device company that develops, manufactures, and markets minimally invasive surgical products. The Company’s products have been developed and marketed for sports medicine; spine/neurologic, ear, nose, and throat; cosmetic; urologic; and gynecologic procedures.
  • HeartWare International Inc (NASDAQ:HTWR): Over the past six months, insiders have bought 22,000 shares and have sold -27,460 shares, for a net of -5,460 shares. The shares recently traded at $64.32 and its market capitalization is $895,392,700. About the company: HeartWare International Inc is developing a range of implantable mechanical circulatory assist devices or heart pumps, used for the treatment of congestive heart failure.
  • Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA): Over the past six months, insiders have bought 545,470 shares and have sold -136,330 shares, for a net of 409,140 shares. The shares recently traded at $17.30 and its market capitalization is $879,749,100. About the company: Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.
  • Meridian Bioscience, Inc. (NASDAQ:VIVO): Over the past six months, insiders have bought 47,530 shares and have sold -15,100 shares, for a net of 32,430 shares. The shares recently traded at $20.89 and its market capitalization is $856,567,700. About the company: Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The Company also offers biopharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.
  • Emeritus Corporation (NYSE:ESC): Over the past six months, insiders have bought 38,340 shares and have sold -180,350 shares, for a net of -142,010 shares. The shares recently traded at $19.00 and its market capitalization is $841,343,200. About the company: Emeritus Corporation is a fully integrated senior housing services company focused on operating residential-style assisted-living communities. The Company develops and operates freestanding assisted living communities throughout the United States. Emeritus has also commenced development of its facilities in Japan and Canada.
  • Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL): Over the past six months, insiders have bought 1,356,870 shares and have sold -1,489,310 shares, for a net of -132,440 shares. The shares recently traded at $17.49 and its market capitalization is $836,724,400. About the company: Auxilium Pharmaceuticals Inc. is a biopharmaceutical company . The Company develops and markets therapeutics to urologists, endocrinologists, orthopedists and select primary care physicians.
  • NPS Pharmaceuticals, Inc. (NASDAQ:NPSP): Over the past six months, insiders have bought 50,000 shares and have sold -50,000 shares, for a net of 0,000 shares. The shares recently traded at $9.58 and its market capitalization is $823,460,500. About the company: NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.
  • The Medicines Company (NASDAQ:MDCO): Over the past six months, insiders have bought 157,040 shares and have sold -886,060 shares, for a net of -729,020 shares. The shares recently traded at $14.81 and its market capitalization is $798,091,700. About the company: The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
  • Genomic Health, Inc. (NASDAQ:GHDX): Over the past six months, insiders have bought 1,546,310 shares and have sold -1,064,640 shares, for a net of 481,670 shares. The shares recently traded at $26.86 and its market capitalization is $786,084,500. About the company: Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company’s diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.
  • AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO): Over the past six months, insiders have bought 127,000 shares and have sold -298,500 shares, for a net of -171,500 shares. The shares recently traded at $18.85 and its market capitalization is $785,352,700. About the company: Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company’s lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.
  • Orthofix International NV (NASDAQ:OFIX): Over the past six months, insiders have bought 20,800 shares and have sold -21,960 shares, for a net of -1,160 shares. The shares recently traded at $41.83 and its market capitalization is $762,926,400. About the company: Orthofix International N.V. and its subsidiaries develop, produce, and market products for the medical device industry. The Company’s products include the Orthofix external fixation, the Spinal Stim for enhanced healing of non-union fractures, the Oscar ultrasonic bone cement removal systems, the Ogden Anchor for anchoring soft tissue to bone, and the Osteogenics BoneSource.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>

More from The Cheat Sheet